Ionis Pharmaceuticals Balance Sheet (2009-2026) | IONS

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	565.12M	632.95M	869.19M	542.51M	521.92M	314.99M	276.47M	309.03M	424.79M	352.06M	399.27M	348.89M	293.99M	334.61M	242.08M	264.19M	297.30M	338.34M	372.26M	173.38M
Short-term Investments (Quarter)	1,494.15M	1,354.15M	1,245.78M	1,509.88M	1,499.91M	1,666.67M	1,710.40M	2,037.75M	1,960.60M	1,883.52M	1,931.93M	1,857.33M	1,784.69M	2,148.67M	2,055.58M	1,880.96M	1,992.68M	1,901.83M	2,305.18M	1,745.73M
Cash & Current Investments (Quarter)	2,059.27M	1,987.10M	2,114.97M	2,052.39M	2,021.83M	1,981.66M	1,986.87M	2,346.78M	2,385.39M	2,235.58M	2,331.20M	2,206.22M	2,078.69M	2,483.28M	2,297.66M	2,145.15M	2,289.98M	2,240.17M	2,677.44M	1,919.11M
Receivables - Other (Quarter)	24.00M	9.07M	61.90M	26.12M	6.75M	6.64M	25.54M	13.91M	27.96M	142.36M	97.78M	5.14M	27.26M	17.93M	92.19M	39.71M	52.58M	24.61M	66.06M	73.68M
Raw Materials (Quarter)	21.59M	16.14M	18.65M	17.93M	15.57M	16.62M	19.76M	20.14M	23.25M	22.81M	1.81M	24.02M	24.62M	21.74M	5.56M	0.64M
Work In Process (Quarter)	0.95M	6.18M	5.77M	5.64M	3.93M	3.74M	2.11M	1.84M	2.09M	2.65M	5.48M	6.04M	3.61M	6.65M	6.68M	8.74M
Finished Goods (Quarter)	1.56M	0.61M	0.39M	0.47M	0.31M	0.29M	0.16M	0.22M	0.20M	0.18M	0.15M	0.20M	0.49M	0.06M	0.28M	2.12M
Inventory (Quarter)	24.10M	22.93M	24.81M	24.03M	19.81M	20.64M	22.03M	22.20M	25.54M	25.63M	7.44M	30.26M	28.72M	28.45M	12.51M	11.50M	8.48M	10.47M	10.05M	5.56M
Prepaid Assets (Quarter)	131.04M	136.64M	143.37M	150.58M	142.76M	143.17M	168.25M	159.72M	177.87M	181.07M	205.43M	174.06M	194.72M	184.19M	217.93M	222.57M	226.11M	243.74M	237.09M	306.08M
Current Assets (Quarter)	2,238.42M	2,155.74M	2,345.05M	2,253.12M	2,191.15M	2,152.13M	2,202.69M	2,542.62M	2,616.75M	2,584.65M	2,641.85M	2,415.68M	2,329.38M	2,713.85M	2,620.29M	2,418.93M	2,577.15M	2,518.99M	2,990.64M	2,936.95M
Non-Current Assets
Land & Improvements (Quarter)
Property, Plant & Equipment (Net) (Quarter)	179.32M	180.14M	178.07M	177.72M	177.01M	180.81M	74.29M	85.16M	91.63M	70.93M	71.04M	72.80M	75.90M	82.50M	94.25M	102.92M	111.95M	106.12M	123.05M	142.40M
Long-Term Investments (Quarter)
Intangibles (Quarter)	29.37M	30.04M	29.00M	29.30M	29.05M	29.61M
Goodwill & Intangibles (Quarter)	29.37M	30.04M	29.00M	29.30M	29.05M	29.61M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)	49.96M	48.97M	70.60M	58.95M	58.92M	59.43M	75.34M	78.30M	86.03M	104.08M	105.28M	106.03M	118.90M	120.32M	127.28M	131.82M	132.10M	165.99M	171.60M	135.56M
Non-Current Assets (Quarter)	258.65M	259.15M	266.64M	265.97M	264.99M	269.85M	331.18M	342.60M	354.38M	349.32M	348.22M	348.25M	361.75M	367.25M	383.38M	394.02M	407.98M	514.10M	533.20M	513.02M
Assets (Quarter)	2,497.07M	2,414.89M	2,611.69M	2,519.09M	2,456.13M	2,421.97M	2,533.88M	2,885.22M	2,971.13M	2,933.97M	2,990.07M	2,763.93M	2,691.13M	3,081.10M	3,003.68M	2,812.95M	2,985.13M	3,033.09M	3,523.84M	3,449.97M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	14.66M	8.36M	11.90M	16.12M	10.35M	20.55M	17.92M	10.50M	24.02M	5.62M	26.03M	13.08M	9.24M	9.05M	42.96M	17.46M	22.80M	14.33M	28.08M	26.03M
Payables (Quarter)	14.66M	8.36M	11.90M	16.12M	10.35M	20.55M	17.92M	10.50M	24.02M	5.62M	26.03M	13.08M	9.24M	9.05M	42.96M	17.46M	22.80M	14.33M	28.08M	26.03M
Accumulated Expenses (Quarter)	75.15M	32.32M	38.81M	99.26M	134.34M	128.00M	140.10M	112.70M	104.75M	118.97M	147.89M	21.54M	114.33M	40.56M	69.61M	102.73M	98.96M	57.02M	116.24M	36.05M
Other Accumulated Expenses (Quarter)			3.53M			13.05M	12.20M	8.24M	10.89M	9.95M	29.60M	9.99M	8.80M	22.06M	19.46M	22.30M	22.81M	24.80M	22.74M	23.39M
Short term Debt (Quarter)	7.97M	3.11M	3.53M	4.21M	4.73M	4.97M					44.33M	44.38M	44.42M	44.47M			630.12M	630.91M	431.95M	432.50M
Current Taxes (Quarter)	1.88M	0.45M	0.04M	0.90M	0.01M	0.02M	6.25M	17.29M	24.73M	31.07M	2.15M	2.21M	0.28M	0.04M	0.03M	0.13M	0.08M	0.10M	2.71M	2.87M
Current Deferred Revenue (Quarter)	102.07M	97.92M	97.71M	91.44M	93.39M	99.51M	90.58M	92.33M	96.25M	204.82M	151.13M	130.41M	94.07M	76.02M	78.99M	81.10M	75.91M	76.99M	73.76M	69.20M
Total Current Liabilities (Quarter)	293.82M	279.78M	240.55M	228.45M	267.81M	283.45M	311.56M	259.22M	287.98M	404.21M	448.09M	327.65M	306.16M	304.57M	309.32M	250.29M	897.24M	903.46M	781.57M	716.59M
Non-Current Liabilities
Capital Leases (Quarter)
Non-Current Debt (Quarter)	60.02M	21.63M	59.71M	25.71M	25.09M	58.98M	15.97M	8.81M			41.84M				51.92M				28.12M
Convertible Debt (Quarter)	541.22M	618.34M	542.31M	542.86M	620.68M	543.96M		623.02M	623.81M	44.29M	562.28M	626.17M	626.96M	564.34M	565.03M	565.72M		567.12M	751.50M	752.42M
Non-Current Deffered Revenue (Quarter)	379.87M	362.89M	351.88M	333.14M	315.20M	294.66M	287.77M	272.97M	254.40M	249.27M	241.18M	215.09M	188.70M	173.78M	156.50M	140.68M	125.09M	107.91M	92.00M	75.75M
Minority Interest (Quarter)
Operating Leases (Quarter)			19.43M				178.94M	177.00M	175.02M	173.04M	170.88M	168.67M	166.44M	168.37M	161.81M	159.39M	164.38M	262.67M	262.38M	259.21M
Other Non-Current Liabilities (Quarter)			6.95M					505.08M	16.44M	48.80M	513.74M	525.07M	533.75M	538.10M	51.92M	55.67M	59.07M	28.79M	28.12M	28.27M
Total Non-Current Liabilities (Quarter)			1,833.01M				1,960.99M	1,893.57M	2,526.39M	2,569.71M	2,089.65M	1,942.34M	1,893.68M	1,880.53M	2,363.40M	2,281.55M	2,294.34M	2,386.34M	3,006.63M	2,930.28M
Total Liabilities (Quarter)	1,914.39M	1,884.36M	1,839.95M	1,809.52M	1,831.41M	1,827.61M	1,960.99M	2,398.65M	2,542.83M	2,618.51M	2,603.39M	2,467.41M	2,427.43M	2,418.63M	2,415.32M	2,337.22M	2,353.41M	2,415.12M	3,034.75M	2,958.55M
Shareholder's Equity
Total Debt (Quarter)	67.99M	24.74M	63.24M	29.92M	29.82M	63.95M	15.97M	8.81M			86.17M	44.38M	44.42M	44.47M	51.92M		630.12M	630.91M	460.07M	432.50M
Common Equity (Quarter)	582.67M	530.54M	771.74M	709.57M	624.73M	594.36M	572.89M	486.57M	428.30M	315.46M	386.69M	296.51M	263.70M	662.47M	588.35M	475.73M	631.72M	617.97M	489.09M	491.41M
Shareholder's Equity (Quarter)	582.67M	530.54M	771.74M	709.57M	624.73M	594.36M	572.89M	486.57M	428.30M	315.46M	386.69M	296.51M	263.70M	662.47M	588.35M	475.73M	631.72M	617.97M	489.09M	491.41M
Liabilities and Shareholders Equity (Quarter)	2,497.07M	2,414.89M	2,611.69M	2,519.09M	2,456.13M	2,421.97M	2,533.88M	2,885.22M	2,971.13M	2,933.97M	2,990.07M	2,763.93M	2,691.13M	3,081.10M	3,003.68M	2,812.95M	2,985.13M	3,033.09M	3,523.84M	3,449.97M
Retained Earnings (Quarter)	-1302.05M	-27.44M	-1159.90M	-48.58M	-1330.20M	-63.14M	-57.48M	-48.98M	-1639.24M	-46.04M	-1795.91M	-1938.71M	-2004.98M	-24.17M	-30.81M	-2396.75M	-27.99M	-25.98M	-2631.20M	-2723.72M
Treasury Shares (Quarter)			2.62M				0.14M				0.23M				0.31M				0.47M

Research Tools

Ionis Pharmaceuticals Balance Sheet (2009-2026) | IONS

Create an account

Sign In

Reset Password